FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Flexion Therapeutics Zilretta Recall

Zilretta (triamcinolone acetonide extended-release injectable suspension), 32mg per via…

Flexion Therapeutics, Inc. · Burlington, MA

Risk level
Class III
Reported by FDA
Jul 8, 2020
Recall ID
D-1376-2020
Check your lot numberHow we source this data

Summary

Flexion Therapeutics recalled Zilretta starting May 19, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1376-2020 on Jul 8, 2020. Reason: Temperature Abuse: Product was stored at room temperature longer than 6 weeks and was inadvertently distributed instead of discarded. Status: Terminated.

Why it was recalled

Temperature Abuse: Product was stored at room temperature longer than 6 weeks and was inadvertently distributed instead of discarded

Product description

Zilretta (triamcinolone acetonide extended-release injectable suspension), 32mg per vial, 5mL vials, Single-dose Kits, Rx Only, Manufactured for: Flexion Therapeutics, Inc. 10 Mall Road, Suite 301, Burlington, MA 01803, NDC 70801-003-01

Lot numbers, UPCs & expiration codes

Lot #: ZA19014, exp. date 05/2021 Only the specific lot distributed by Besse Medical are affected.

Where it was sold

Nationwide within the United States only lots distributed by Besse Medical are affected.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1376-2020
Classification
Class III
Status
Terminated
Recall initiated
May 19, 2020
FDA report date
Jul 8, 2020
Quantity
792 kits
Recall type
Voluntary: Firm initiated
Recalling firm
Flexion Therapeutics, Inc.

Original FDA data

Every field from FDA enforcement report D-1376-2020, exactly as published.

Show all FDA fields
City
Burlington
State
MA
Status
Terminated
Country
United States
Event ID
85742
Address
10 Mall Rd Ste 301
Code information
Lot #: ZA19014, exp. date 05/2021 Only the specific lot distributed by Besse Medical are affected.
Postal code
01803-4121
Report date
Jul 8, 2020
Product type
Drugs
Recall number
D-1376-2020
Classification
Class III
Recalling firm
Flexion Therapeutics, Inc.
Product quantity
792 kits
Termination date
Nov 3, 2020
Reason for recall
Temperature Abuse: Product was stored at room temperature longer than 6 weeks and was inadvertently distributed instead of discarded
Voluntary / mandated
Voluntary: Firm initiated
Product description
Zilretta (triamcinolone acetonide extended-release injectable suspension), 32mg per vial, 5mL vials, Single-dose Kits, Rx Only, Manufactured for: Flexion Therapeutics, Inc. 10 Mall Road, Suite 301, Burlington, MA 01803, NDC 70801-003-01
Distribution pattern
Nationwide within the United States only lots distributed by Besse Medical are affected.
Recall initiation date
May 19, 2020
Initial firm notification
Letter
Center classification date
Jul 8, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1376-2020, published Jul 8, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls